Literature DB >> 2496622

Immunoquantitation of aldose reductase in human tissues.

C E Grimshaw1, E J Mathur.   

Abstract

Rabbit antibodies raised against bovine kidney aldose reductase (ALR2) were shown to be monospecific for human ALR2 by Western blot analysis of human muscle homogenates. The human enzyme was detected, by reaction with the antiserum (alpha-BKALR2), in homogenates of adrenal gland, muscle, lens, brain, testes, kidney, and placenta, but not in erythrocytes or leukocytes. The amount of enzyme in each tissue was determined by densitometric analysis of autoradiographs of Western blots probed with alpha-BKALR2 and [125I]protein A. Standard curves of radiographic intensity versus amount of purified human muscle ALR2 were linear in the 20 to 200-ng range; a similar sensitivity was seen in tissue homogenates containing up to 675 micrograms total protein. The results presented here for the ALR2 level in human tissues (adrenal greater than muscle greater than lens approximately brain approximately testes greater than kidney approximately placenta) are in agreement with literature values for those tissues from which the enzyme has previously been purified. A notable exception was the absence of detectable ALR2 in human erythrocytes. A quantitative comparison of immunoradiographic response showed that bovine kidney ALR2 was about sevenfold more reactive with a alpha-BKALR2 compared to the human muscle enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496622     DOI: 10.1016/0003-2697(89)90273-x

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in man.

Authors:  R K Brazzell; P R Mayer; R Dobbs; P J McNamara; R L Teng; J T Slattery
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

2.  Substrate specificity of sheep liver sorbitol dehydrogenase.

Authors:  R I Lindstad; P Köll; J S McKinley-McKee
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

4.  Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Authors:  Matthew Spite; Shahid P Baba; Yonis Ahmed; Oleg A Barski; Kanchan Nijhawan; J Mark Petrash; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

5.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.

Authors:  T O'connor; L S Ireland; D J Harrison; J D Hayes
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

6.  Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.

Authors:  Bernat Crosas; David J Hyndman; Oriol Gallego; Sílvia Martras; Xavier Parés; T Geoffrey Flynn; Jaume Farrés
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

7.  Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers.

Authors:  Toshiyuki Matsunaga; Yasuhiro Wada; Satoshi Endo; Midori Soda; Ossama El-Kabbani; Akira Hara
Journal:  Front Pharmacol       Date:  2012-01-31       Impact factor: 5.810

8.  Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling.

Authors:  F Xavier Ruiz; Sergio Porté; Xavier Parés; Jaume Farrés
Journal:  Front Pharmacol       Date:  2012-04-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.